Hyperglycemia and altered insulin signaling in T1DM, along with hyperglycemia, insulin resistance, and dyslipidemia in T2DM, result in dysfunction of the endoplasmic reticulum and mitochondria, systemic inflammation, and oxidative stress (OS). The gene discussed is INS; the disease is metabolic syndrome.